OPT Congress: Oligonucleotide & Precision Therapeutics

OPT Congress is the premier conference for professionals involved in discovering and developing oligonucleotide therapeutics. Now in its 8th year, this unique event brings together leading discovery scientists, developers, CMC experts, regulatory specialists and technology providers to discuss advances in next-generation oligonucleotide and precision therapeutics throughout the drug development process. New this year, we are delighted to announce a third conference program dedicated to Emerging mRNA Therapeutics to complement our established Oligo Discovery & Delivery and CMC & Regulatory programs. In addition to 2 days of inspiring keynotes, interactive discussions and more than 55 scientific presentations, we deliver an in-depth course focusing on the Safety & Toxicity of Nucleic Acids. Join your peers and industry experts as together we optimize drug design, delivery and performance, accelerate time to market and achieve commercial success.

When and Where